Key facts
- This page summarizes Yin Weidong's Form 3 filing for SINOVAC BIOTECH LTD (SVA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 08:08.
Yin Weidong - 18 Mar 2026 Form 3 Insider Report for SINOVAC BIOTECH LTD (SVA)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- SVA
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jia Zhao, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Yin Weidong filed Form 3 for SINOVAC BIOTECH LTD (SVA) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001264738
Primary reporting owner
WEIDONG YIN
- Relationship
- Chief Executive Officer, Director
- Address
- NO. 39 SHANGDI XI ROAD, HAIDIAN DISTRICT, BEIJING, CHINA
- Signature
- /s/ Jia Zhao, Attorney-in-Fact
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SVA
holding
Common shares, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,359,500
- Date
- 18 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney